Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online

Anti-PAR4抗体(ab5787)

Submit a review Q&A (3)References (5)
Western blot - Anti-PAR4 antibody (ab5787)

    Key features and details

    • Rabbit polyclonal to PAR4
    • Suitable for: WB
    • Reacts with: Rat
    • Isotype: IgG

    选择批间可重复性更高的重组抗体

    Product image
    Anti-PAR4 antibody [EPR3992] (ab109174)
    • 研究可靠 —— 各批次间结果一致且可重复
    • 长期批量供应 —— 采用重组技术，可实现快速生产
    • 首次实验即可成功 —— 经过大量验证确认了特异性
    • 符合伦理标准 —— 产品不含动物成分

    概述

    • 产品名称

      Anti-PAR4抗体
      参阅全部 PAR4 一抗

    • 描述

      兔多克隆抗体to PAR4

    • 宿主

      Rabbit

    • 经测试应用

      适用于: WBmore details

    • 种属反应性

      与反应: Rat

    • 免疫原

      Synthetic peptide corresponding to Human PAR4 aa 324-342.
      Sequence:

      EQLKQENKTLLKVVGQLTR


      (Peptide available as ab5853)
      Run BLAST with BLAST the sequence with ExPASy Run BLAST with BLAST the sequence with NCBI

    • 阳性对照

      • WB: Rat spleen extract.

    • 常规说明

      The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.

      If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As

    性能

    应用

    The Abpromise guarantee

    Abpromise™承诺保证使用ab5787于以下的经测试应用

    “应用说明”部分 下显示的仅为推荐的起始稀释度；实际最佳的稀释度/浓度应由使用者检定。

    应用 Ab评论 说明
    WB
    Use a concentration of 2 µg/ml. Detects a band of approximately 40 kDa (predicted molecular weight: 41 kDa).
    说明
    WB
    Use a concentration of 2 µg/ml. Detects a band of approximately 40 kDa (predicted molecular weight: 41 kDa).

    靶标

    • 功能

      Pro-apoptopic protein capable of selectively inducing apoptosis in cancer cells, sensitizing the cells to diverse apoptotic stimuli and causing regression of tumors in animal models. Induces apoptosis in certain cancer cells by activation of the Fas prodeath pathway and coparallel inhibition of NF-kappa-B transcriptional activity. Inhibits the transcriptional activation and augments the transcriptional repression mediated by WT1. Down-regulates the anti-apoptotic protein BCL2 via its interaction with WT1. Seems also to be a transcriptional repressor by itself. May be directly involved in regulating the amyloid precursor protein (APP) cleavage activity of BACE1.

    • 组织特异性

      Widely expressed. Expression is elevated in various neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer, Parkinson and Huntington diseases and stroke. Down-regulated in several cancers.

    • 结构域

      The leucine-zipper domain is not essential for apoptosis, but is required for sensitization of cells to exogenous apoptotic insults and for interaction with its partners.
      The SAC domain is a death-inducing domain selective for apoptosis induction in cancer cells. This domain is essential for nuclear entry, Fas activation, inhibition of NF-kappa-B activity and induction of apoptosis in cancer cells.

    • 翻译后修饰

      Preferentially phosphorylated at the Thr-163 by PKC in cancer cells.

    • 细胞定位

      Cytoplasm. Nucleus. Mainly cytoplasmic in absence of apoptosis signal and in normal cells. Nuclear in most cancer cell lines. Nuclear entry seems to be essential but not sufficient for apoptosis (By similarity). Nuclear localization includes nucleoplasm and PML nuclear bodies.
    • Information by UniProt

    • 数据库链接

      • 别名

        • 2310001G03Rik antibody
        • PAR 4 antibody
        • PAR-4 antibody
        • Pawr antibody
        • PAWR_HUMAN antibody
        • PRKC Apoptosis WT1 Regulator antibody
        • PRKC apoptosis WT1 regulator protein antibody
        • Prostate apoptosis response 4 protein antibody
        • Prostate apoptosis response protein 4 antibody
        • prostate apoptosis response protein PAR-4 antibody
        • Transcriptional repressor Par-4-like protein PAWR antibody
        • Transcriptional repressor PAR4 antibody
        • WT1 Interacting Protein antibody
        see all

      图片

      • Western blot - Anti-PAR4 antibody (ab5787)
        Western blot - Anti-PAR4 antibody (ab5787)
        Anti-PAR4 antibody (ab5787) + Rat spleen extract

        Predicted band size: 41 kDa

      文献 (5)

      发表研究结果有使用 ab5787？请让我们知道，以便我们可以引用本数据表中的参考文章。

      ab5787 被引用在 5 文献中.

      • Guo H  et al. PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1. Sci Rep 9:8755 (2019). PubMed: 31217499
      • Acharya M  et al. A complex regulatory network of transcription factors critical for ocular development and disease. Hum Mol Genet 20:1610-24 (2011). IP . PubMed: 21282189
      • Fernandez-Marcos PJ  et al. Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma. Proc Natl Acad Sci U S A 106:12962-7 (2009). IHC-P ; Human . PubMed: 19470463
      • Acharya M  et al. Human PRKC apoptosis WT1 regulator is a novel PITX2-interacting protein that regulates PITX2 transcriptional activity in ocular cells. J Biol Chem 284:34829-38 (2009). WB, IHC-P ; Human, Mouse . PubMed: 19801652
      • Chung H  et al. IGF-I inhibition of apoptosis is associated with decreased expression of prostate apoptosis response-4. J Endocrinol 194:77-85 (2007). PubMed: 17592023

      客户评价及客户问答

      Show All 评价 Q&A
      提交评价 提交问题

      1-3 of 3 Abreviews or Q&A

      Question

      vielen Dank für die schnelle Antwort. Da wir auf der Suche nach einem PAR-4 Antikörper sind, der PAR-4 C-terminal von der Caspase Schnittstelle erkennt, hätte Abcam ja noch einen zur Auswahl. (PAR-4 rab polycl. ab5787; Immunogen Synthetic peptide: EQLKQENKTLLKVVGQLTR, corresponding to amino acids 324-342 of Human PAR4).
      Den hätten wir als Ersatz für den PAR-4 ab49155 bitte zugeschickt. Falls Sie noch weitere Infos benötigen stehe ich Ihnen gerne zur Verfügung.

      Read More
      Answer

      Vielen Dank für Ihre Nachricht.

      Es tut mir leid, dass Sie Probleme mit diesem PAR4-Antikörper hatten. Wie besprochen, habe ich eine kostenlose Ersatzlieferung mit ab5787für Sie in Auftrag gegeben. Sie hat die Referenznummer x und solltenach dem 1. Maibei Ihnen ankommen.

      Ich wünsche Ihnen viel Erfolg für Ihr Projekt. Bitte zögern Sie nicht, sich wieder bei uns zu melden, falls Sie weitere Fragen haben.

      Read More

      Question

      Would like positive and negative control tissue slides for TRAIL and PAR4. Needs blocking peptide for PAR4 antibody as it is ubiquitously expressed.

      Read More
      Answer

      Thanks for your call earlier this week and for your patience. The immunogenic peptide for the PAR4 antibody ab5787 is available as ab5853- https://www.abcam.com/PAR4-peptide-ab5853.html You can use this peptide in a blocking assay in order to demonstrate the specificity of the antibody, since there is not negative control tissue available. Please let me know if you have any questions or if there is anything else that I can do for you.

      Read More

      Question

      I have a complaint about the Par4 antibody AB5787 (Lot. 45056) which seems to bind unspecific in WB of HT22 celllysate. Our customer has reviewed your suggestions and done some additional experiments - unfortunately without success. Here are his answers to your questions: 1. This antibody has been characterized on human and rat samples for Western blot application. Other species have not been tested so we do not know if it recognizes mouse PAR4. It is expected to cross-react with mouse (100% identity with immunogen) due to sequence homology but we have no data yet. - "Now tried the antibody with proteins extracted from rat neurons. The result was as bad as before". 2. As I understand the customer has multiple bands. How much protein was loaded onto the gel? We usually recommend 20-30 ug total protein/lane. If the gel is overloaded, multiple bands can be seen. - "I loaded the gel several times with 50µg and several times with 25µg protein. At the lower loaded gel there also were mutliple bands". 3. Has the customer used protease inhibitors in the lysis buffer? No information in the e-mail. - "There was protease inhibitor cockatil in the lysis buffer". 4. It is also important to test the secondary antibody "run a secondary control" to see if the detection system works properly. Has he tested this? Or has he used the same secondary antibody with another primary antibody? What exactly the specification of the secondary antibody? - "The secondary antibody is polyclonal anti rabbit and it works great with other primary antibodies". 5. We would also recommend using positive control along with the samples. Rat tissue extracts, including testes, spleen, ovary, lung, and skeletal muscle would be good positive control. The customer should be able to see a 40 kDa and a 38 kDa protein bands. - "In cells transfected with Par4-Plasmid I cant see any bands at 40 or 38 kDa. Just the many other bands". Do you have any further suggestions?

      Read More
      Answer

      Thank you for your patience. In reviewing the information, we see Western blot with multiple bands at 40 kDa, 38 kDa and unknown at 20 kDa. It is most likely that the preparation, protocol or storage of antibody that is causing the extra bands. There may be homologous sequences in this protein because in reference papers, we noticed all the researchers have cut out the target band and did not reveal the entire blot. This occurs mostly when they want to avoid revealing multiple bands. We would suggest increasing the stringency of their washes and blocking (increase detergent/salt concentration, increase temperatures and times, while decreasing the concentration of primary antibody being used.) We would also recommend using positive controls, to show which bands are relevant. We hope this helps.

      Read More

      Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
      For licensing inquiries, please contact partnerships@abcam.com